Neogen (NEOG) Competitors $5.88 -0.05 (-0.84%) Closing price 04:00 PM EasternExtended Trading$6.08 +0.20 (+3.32%) As of 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEOG vs. MMSI, ICUI, XRAY, HAE, QDEL, STAA, CERS, OSUR, UTMD, and ANIKShould you be buying Neogen stock or one of its competitors? The main competitors of Neogen include Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), and Anika Therapeutics (ANIK). These companies are all part of the "health care supplies" industry. Neogen vs. Its Competitors Merit Medical Systems ICU Medical DENTSPLY SIRONA Haemonetics QuidelOrtho STAAR Surgical Cerus OraSure Technologies Utah Medical Products Anika Therapeutics Merit Medical Systems (NASDAQ:MMSI) and Neogen (NASDAQ:NEOG) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends. Is MMSI or NEOG more profitable? Merit Medical Systems has a net margin of 8.31% compared to Neogen's net margin of -117.61%. Merit Medical Systems' return on equity of 15.07% beat Neogen's return on equity.Company Net Margins Return on Equity Return on Assets Merit Medical Systems8.31% 15.07% 8.60% Neogen -117.61%2.23%1.42% Which has more risk & volatility, MMSI or NEOG? Merit Medical Systems has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500. Comparatively, Neogen has a beta of 1.9, suggesting that its share price is 90% more volatile than the S&P 500. Does the media refer more to MMSI or NEOG? In the previous week, Merit Medical Systems had 5 more articles in the media than Neogen. MarketBeat recorded 13 mentions for Merit Medical Systems and 8 mentions for Neogen. Merit Medical Systems' average media sentiment score of 0.88 beat Neogen's score of 0.46 indicating that Merit Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 7 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Neogen 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings and valuation, MMSI or NEOG? Merit Medical Systems has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMerit Medical Systems$1.36B3.57$120.36M$1.9741.55Neogen$894.66M1.43-$1.09B-$4.80-1.23 Do insiders & institutionals believe in MMSI or NEOG? 99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 96.7% of Neogen shares are owned by institutional investors. 3.2% of Merit Medical Systems shares are owned by insiders. Comparatively, 0.6% of Neogen shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Do analysts recommend MMSI or NEOG? Merit Medical Systems presently has a consensus price target of $106.50, indicating a potential upside of 30.10%. Neogen has a consensus price target of $8.83, indicating a potential upside of 50.23%. Given Neogen's higher possible upside, analysts plainly believe Neogen is more favorable than Merit Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Merit Medical Systems 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89Neogen 1 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryMerit Medical Systems beats Neogen on 14 of the 16 factors compared between the two stocks. Get Neogen News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEOG vs. The Competition Export to ExcelMetricNeogenMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.29B$10.91B$6.11B$10.51BDividend YieldN/A1.88%5.73%4.81%P/E Ratio-1.2313.8063.4522.93Price / Sales1.4326.54609.45131.82Price / Cash1.0325.0337.1661.22Price / Book0.603.4112.246.52Net Income-$1.09B$210.63M$3.32B$276.75M7 Day Performance-2.65%0.03%0.76%0.92%1 Month Performance7.69%0.19%8.03%4.20%1 Year Performance-59.34%-9.15%71.13%37.86% Neogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEOGNeogen3.4026 of 5 stars$5.88-0.8%$8.83+50.2%-59.4%$1.29B$894.66M-1.232,110Analyst ForecastMMSIMerit Medical Systems4.6832 of 5 stars$79.43+0.6%$107.50+35.3%-15.2%$4.68B$1.36B40.327,400News CoveragePositive NewsAnalyst ForecastICUIICU Medical4.5973 of 5 stars$116.26+1.9%$181.00+55.7%-36.6%$2.82B$2.38B-76.4915,000News CoverageXRAYDENTSPLY SIRONA4.7808 of 5 stars$12.21+3.2%$18.00+47.4%-48.8%$2.36B$3.79B-2.5814,000Analyst RevisionGap UpHAEHaemonetics4.9291 of 5 stars$50.25+2.9%$75.89+51.0%-34.1%$2.35B$1.36B15.373,023QDELQuidelOrtho4.1362 of 5 stars$26.31-0.2%$37.80+43.7%-28.9%$1.79B$2.78B-4.026,600STAASTAAR Surgical3.2196 of 5 stars$27.25+2.1%$20.67-24.2%-24.3%$1.32B$313.90M-14.121,211CERSCerus2.7423 of 5 stars$1.56-2.5%$3.50+124.4%-12.2%$306.72M$180.27M-15.60290News CoveragePositive NewsShort Interest ↓OSUROraSure Technologies2.0835 of 5 stars$3.01+2.0%$3.00-0.3%-24.8%$215.75M$185.83M-4.49840UTMDUtah Medical Products2.2229 of 5 stars$60.53-1.3%N/A-9.3%$196.61M$40.90M16.18180Gap UpANIKAnika Therapeutics4.4809 of 5 stars$9.10+0.9%$18.00+97.8%-63.9%$130.05M$119.91M-2.19300Positive NewsShort Interest ↓ Related Companies and Tools Related Companies MMSI Competitors ICUI Competitors XRAY Competitors HAE Competitors QDEL Competitors STAA Competitors CERS Competitors OSUR Competitors UTMD Competitors ANIK Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEOG) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neogen Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Neogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
